Showing results (1-10 of 781) with videos related to
Sort By:
Pageof 79
Oncotarget|September 20, 2012
Bruton's tyrosine kinase: oncotarget in myelomaYu-Tzu Tai, Kenneth C AndersonImmunotherapy|September 16, 2015
Targeting B-cell maturation antigen in multiple myelomaYu-Tzu Tai, Kenneth C AndersonBone Marrow Research|November 3, 2011
Antibody-based therapies in multiple myelomaYu-Tzu Tai, Kenneth C AndersonExpert Opinion on Biological Therapy|July 7, 2019
B cell maturation antigen (BCMA)-based immunotherapy for multiple myelomaYu-Tzu Tai, Kenneth C AndersonImmunotargets and Therapy|October 29, 2020
Immunotherapeutic and Targeted Approaches in Multiple MyelomaOmar Nadeem, Yu-Tzu Tai, Kenneth C AndersonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2022
Microenvironment Is a Key Determinant of Immune Checkpoint Inhibitor ResponseShih-Feng Cho, Kenneth C Anderson, Yu-Tzu TaiFrontiers in Immunology|August 28, 2018
Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based ImmunotherapyShih-Feng Cho, Kenneth C Anderson, Yu-Tzu TaiFrontiers in Immunology|August 28, 2018
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1Yu-Tzu Tai, Shih-Feng Cho, Kenneth C AndersonDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 16, 2005
Perspectives for combination therapy to overcome drug-resistant multiple myelomaLaurence Catley, Yu-Tzu Tai, Dharminder Chauhan, et al.Clinical Pharmacology : Advances and Applications|August 26, 2021
Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and SelinexorNisha S Joseph, Yu-Tzu Tai, Kenneth C Anderson, et al.Pageof 79